Significance of low level infliximab in the absence of anti-infliximab antibodies

Bella Ungar*, Adi Anafy, Henit Yanai, Yulia Ron, Miri Yavzori, Orit Picard, Ella Fudim, Ronen Loebstein, Uri Kopylov, Yehuda Chowers, Iris Dotan, Rami Eliakim, Shomron Ben-Horin

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Significance of low level infliximab in the absence of anti-infliximab antibodies'. Together they form a unique fingerprint.

Medicine & Life Sciences